-
- Posted Wednesday May 15, 2019
Trends Charitable Fund names TGen beneficiary, supporting women’s and children’s research
‘Evening of Trends 2019,’ gala set for Nov. 1 at Omni Scottsdale Resort & Spa at Montelucia
PHOENIX, Ariz. — May 15, 2019 — For the second year in a row, Trends Magazine and the Trends Charitable Fund (TCF) has selected the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, as the beneficiary of its annual fall gala.
The Trends Charitable Fund board again selected TGen because of the biomedical research institute’s innovative genomic technologies and its commitment toward discovery of new treatments and cures for women’s cancers and childhood disorders.
“We are very happy to provide a second year of support to such a wonderful organization as TGen,” said Susie Wesley, the 2019 TCF Board President.
The TCF Evenings of Trends 2019, A Desert serenade, starts at 6 p.m. Friday, Nov. 1, at the Omni Scottsdale Resort & Spa at Montelucia, 4949 E. Lincoln Drive. Tickets range from $500 for individuals to $25,000 for a table for 10. For more information or to donate to the Trends Charitable Fund, visit: www.trendscharitablefund.org.
This past October, TCF’s Evening of Trends 2018 raised more than $275,000 for TGen, specifically for Ovarian Cancer Research and also for TGen’s Center for Rare Childhood Disorders, including funds for genetic sequencing, which can help doctors treat TGen’s pediatric patients.
“We are thrilled to once again receive the support of Trends Magazine and the Trends Charitable Fund,” said Erin Massey, Chief Development Officer at TGen, and Vice President of Philanthropy at City of Hope. “These dollars contribute to the success of TGen by helping advance our research into diseases that directly impact women, children and their families.”
Since its founding in 2002, Phoenix-based TGen has become a global leader in precision medicine, a rapidly evolving field of biomedical science that uses the power of the human genome to transform the diagnosis, treatment and prevention of cancer and other life-threatening diseases.
Established in 1986, Trends Charitable Fund has granted more than $5 million to charities benefiting Arizona women, children and families.
“The work of TGen is such a natural fit with the mission of Trends Charitable Fund, which supports programs that positively impact women, children and their families,” said Vicki Vaughn, Co-Chair of Evening of Trends 2019.
# # #
About Trends Magazine
Trends Magazine focuses on Arizona society, fashion, home, dining and art. It is published seven times a year, from November to May, at the end of each of those months. For more information, contact publisher Bill Dougherty at [email protected] or 480-990-9007.
About TGen, an affiliate of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life-changing results. TGen is affiliated with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases: www.cityofhope.org. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org. Follow TGen on Facebook, LinkedIn and Twitter @TGen.
Media Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
